Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

ClinicalTrials.gov ID: NCT01327547

Public ClinicalTrials.gov record NCT01327547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 10:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Blinded, Placebo-controlled Study To Evaluate The Safety Of Maraviroc In Combination With Other Antiretroviral Agents In Hiv-1-infected Subjects Co-infected With Hepatitis C And/or Hepatitis B Virus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To describe liver enzyme elevations in patients who are coinfected with HIV and either Hepatitis C (HCV) and/or Hepatitis B (HBV) receiving maraviroc or placebo in combination with their current suppressive anti-HIV drug therapy.

Study identification

NCT ID
NCT01327547
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
ViiV Healthcare
Industry
Enrollment
138 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2011 (Actual)
Primary completion
Apr 23, 2013 (Actual)
Completion
Mar 24, 2015 (Actual)
Last update posted
Dec 6, 2017

2011 – 2015

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
The Office of Dr. Franco Antonio Felizarta, M.D. Bakersfield California 93301 —
AIDS Research Alliance Los Angeles California 90015 —
Alameda Health System - Highland Hospital Oakland California 94602 —
University of California Davis Research Sacramento California 95811 —
University of California Sacramento California 95817 —
University of California, San Francisco - Hepatitis/HIV Clinical Trials Group (HHCTG) San Francisco California 94110 —
University of California, San Francisco - Mt. Zion Hospital San Francisco California 94115 —
Community AIDS Resource Inc dba Care Resource Miami Florida 33137 —
University of South Florida Health - HIV Clinical Research Unit Tampa Florida 33602 —
Rowan Tree Medical, P.A. Wilton Manors Florida 33305 —
Georgia Regents Medical Center Augusta Georgia 30912 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Henry Ford Hospital Detroit Michigan 48202 —
Saint Michael's Medical Center Newark New Jersey 07102 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Mount Sinai Faculty Practice Associates New York New York 10029 —
The Mount Sinai Hospital New York New York 10029 —
New York Medical College Valhalla New York 10595 —
I.D. Consultants, P.A. Charlotte North Carolina 28209 —
Kaiser Permanente Sunnybrook Medical Office Clackamas Oregon 97015 —
Kaiser Permanente Northwest Portland Oregon 97227 —
Southwest Infectious Disease Clinical Research Inc. Dallas Texas 75219 —
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235 —
University Health Care Center Downtown San Antonio Texas 78207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01327547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2017 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01327547 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →